Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-based care
Article first published online: 23 JUL 2012
© 2012 The Author(s)/Acta Pædiatrica © 2012 Foundation Acta Pædiatrica
Volume 101, Issue 10, pages 1069–1073, October 2012
How to Cite
Tiberg, I., Katarina, S. C., Carlsson, A. and Hallström, I. (2012), Children diagnosed with type 1 diabetes: a randomized controlled trial comparing hospital versus home-based care. Acta Paediatrica, 101: 1069–1073. doi: 10.1111/j.1651-2227.2012.02775.x
- Issue published online: 29 AUG 2012
- Article first published online: 23 JUL 2012
- Accepted manuscript online: 3 JUL 2012 02:35PM EST
- Received 14 March 2012; revised 31 May 2012; accepted 26 June 2012.
- Health services;
- Management regimen;
- Randomized controlled trial;
- Type 1 diabetes
Aim: To compare two different regimens for children diagnosed with type 1 diabetes: hospital-based care or hospital-based home care (HBHC), referring to specialist care in a home-based setting.
Method: The trial took place in Sweden with a randomized controlled design and included 60 children, aged 3–15 years. After 2–3 days with hospital-based care, children were randomized to either continued hospital-based care or to HBHC for 6 days. The primary outcome was the child’s metabolic control after 2 years. Secondary outcomes were set to evaluate the family and child situation as well as the healthcare services. This article presents data 6 months after diagnosis.
Results: Results showed equivalence between groups in terms of metabolic control, insulin dose, parents’ employment and working hours as well as parents’ and significant others’ absence from work related to the child’s diabetes. Parents in the HBHC were more satisfied with the received health care and showed less subsequent healthcare resource use. The level of risk for the family’s psychosocial distress assessed at diagnosis was associated with the subsequent use of resources, but not with metabolic control.
Conclusion: HBHC was found to be an equally safe and effective way of providing care as hospital-based care at the onset of type 1 diabetes for children who are medically stable.